Richard A. Bender, M.D.; Heine H. Hansen, M.D.
This content is PDF only. Please click on the PDF icon to access.
A prospective study of 200 consecutive, unresectable patients with bronchogenic carcinoma was conducted over a 3-year period to determine the incidence of hypercalcemia (serum calcium greater than 10.5 mg/100 ml) and its relation to histologic cell type and to osseous metastases. Seventeen of the patients had calcium elevations at the time of diagnosis, and eight developed it subsequently, indicating an overall incidence of 12.5%. Seven percent had hypercalcemia in the absence of osseous involvement. Eighteen of the 78 patients (23%) with epidermoid carcinoma, 6 of 47 (12.8%) with large cell anaplastic carcinoma, and 1 of 40 (2.5%) with adenocarcinoma presented
Bender RA, Hansen HH. Hypercalcemia and Bronchogenic Carcinoma, A Prospective Study of 200 Patients.. Ann Intern Med. ;78:831–832. doi: 10.7326/0003-4819-78-5-831_4
Download citation file:
Published: Ann Intern Med. 1973;78(5):831-832.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use